<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<!--<?xml-stylesheet type="text/xsl" href="article.xsl"?>-->
<article article-type="review-article" dtd-version="1.0" xml:lang="en"
    xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <front>
        <journal-meta>
            <journal-id journal-id-type="issn">0973-7510</journal-id>
            <journal-title-group>
                <journal-title>Journal of Pure and Applied Microbiology</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2581-690X</issn>
            <publisher>
                <publisher-name>DR. M.N. Khan</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.22207/JPAM.20.4.21</article-id>
            <title-group>
                <article-title>Beyond the Lungs: Unveiling the Long-term Hepatobiliary Complications of COVID-19</article-title>
            </title-group>
 
			<contrib-group>


				<contrib contrib-type="author">
                    <name>
                        <surname>Aldobashi</surname>
                        <given-names>Hamad</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
			
			
				<contrib contrib-type="author">
                    <name>
                        <surname>Ahmad</surname>
                        <given-names>Marwah Nasir</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
			
			
				<contrib contrib-type="author">
                    <name>
                        <surname>Mouazen</surname>
                        <given-names>Saaid</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
		<contrib contrib-type="author">
                    <name>
                        <surname>Alsubhi</surname>
                        <given-names>Mohammed</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
				<contrib contrib-type="author">
                    <name>
                        <surname>Muawwadh</surname>
                        <given-names>Elaf</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
			
			
				<contrib contrib-type="author">
                    <name>
                        <surname>Alqamshi</surname>
                        <given-names>Raghad</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-2"/>
                </contrib>
			
			
				<contrib contrib-type="author">
                    <name>
                        <surname>El Said</surname>
                        <given-names>Manal</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-3"/>
                    <xref ref-type="aff" rid="aff-4"/>
                </contrib>
			</contrib-group>


                    <aff id="aff-1">General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.</aff>
					<aff id="aff-2">Department of Medicine, University of Tabuk, Tabuk, Saudi Arabia.</aff>
					<aff id="aff-3">Department of Microbiology, General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.</aff>
					<aff id="aff-4">Department of Microbiology and Infection Prevention and Control Unit, Theodor Bilharz Research Institute, Giza, Egypt.</aff>


            <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-11-11">
                <day>11</day>
				<month>11</month>
                <year>2026</year>
            </pub-date>
            <volume></volume>
            <issue></issue>
            <fpage></fpage>
            <lpage></lpage>
            <permissions>
                <copyright-statement>Copyright &#x00A9; 2026 The Author(s)</copyright-statement>
                <copyright-year>2026</copyright-year>
                <license license-type="open-access"
                    xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.<uri
					xlink:href="https://creativecommons.org/licenses/by/4.0/"
                            >https://creativecommons.org/licenses/by/4.0/</uri></license-p>
                </license>
            </permissions>
            <self-uri xlink:href="https://microbiologyjournal.org/beyond-the-lungs-unveiling-the-long-term-hepatobiliary-complications-of-covid-19/"/>
            <abstract>
                <p>Although primarily known for its respiratory involvement, SARS-CoV-2 infection has increasingly been associated with significant effects on multiple organ systems, including the hepatobiliary tract. Over the course of the pandemic, it was shown that COVID-19 can trigger a variety of liver and cholangiocyte impairments through many overlapping mechanisms. These include entry of the virus into liver cells that express angiotensin-converting enzyme 2 receptors, impaired immune responses, ischemic injury, and adverse reactions to therapeutic drugs. These may lead to persistent hepatic enzyme abnormalities, biliary stasis, secondary sclerosing cholangitis, or fibrosis. Individuals who have underlying liver disease, such as liver cirrhosis or non-alcoholic fatty liver disease (NAFLD), are especially susceptible to serious complications and unfavorable outcomes. Uncommon immune-mediated conditions, such as post-COVID-19 vaccination autoimmune-like hepatitis, have been reported. Therefore, ongoing assessment of liver function and careful long-term follow-up are recommended for patients with post-COVID-19 syndrome, especially those at high risk. This review discusses current evidence to provide an overview of the mechanisms, manifestations, and long-term consequences of COVID-19 involving the hepatobiliary tract.</p></abstract>
		<kwd-group>
        <title>Keywords</title>
        <kwd>Post-Acute COVID-19 Syndrome</kwd>
        <kwd>Cholangiopathy</kwd>
        <kwd>Secondary Sclerosing Cholangitis</kwd>
        <kwd>Autoimmune Hepatitis</kwd>
        <kwd>Drug-Induced Liver Injury</kwd>
        <kwd>Liver Fibrosis</kwd>
		</kwd-group>
</article-meta>
</front>
</article>